Annie WC Kung, Keith DK Luk, LW Chu, and Peter KY Chiu
|
|
- Kory Smith
- 5 years ago
- Views:
Transcription
1 Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation 1 3 Annie WC Kung, Keith DK Luk, LW Chu, and Peter KY Chiu ABSTRACT Background: Age-related osteoporosis may be associated with inefficient intestinal calcium absorption and bone remodeling. Objective: We investigated the pathogenesis of age-related osteoporosis in Chinese women with habitual low calcium intakes. Design: We studied the response of intestinal calcium absorption, calcitropic hormones, and biochemical bone markers to graded dietary calcium deprivation. Results: The osteoporotic subjects (n = 25) had higher urinary calcium excretion (P < 0.05) and lower plasma 1,25-dihydroxyvitamin D concentrations (P < 0.02) than did age-matched control women (n = 25). Parathyroid hormone was not significantly different from that in age-matched control women but was significantly higher than in young women (n = 15, P < 0.05). Fractional 45 Ca absorption was 61% in all 3 groups when the diet was unmodified and increased to 71%, 69%, and 68% in the osteoporotic subjects, age-matched control women, and young women, respectively, when dietary calcium was reduced to 300 mg/d. When the osteoporotic women were calcium deprived, serum 1,25-dihydroxyvitamin D failed to increase but urinary calcium excretion persisted. In contrast, supplementation with 1200 mg Ca resulted in a lowering of parathyroid hormone (P < compared with the unmodified diet) and 1,25-dihydroxyvitamin D (P < 0.01) and decreased fractional 45 Ca absorption (P < 0.01), suggesting that the increased calcium intake was associated with a potent compensatory ability of the intestine and calcitropic hormones to adapt. Calcium supplementation lowered osteocalcin (P < 0.05) but not alkaline phosphatase, which remained elevated in the osteoporotic subjects at all stages. Conclusions: Elderly osteoporotic women had reduced 1,25-dihydroxyvitamin D production, excessive urinary calcium loss, and high bone turnover. The Chinese women had exceptionally potent intestinal calcium absorption. Am J Clin Nutr 1998;68: KEY WORDS Osteoporosis, calcium absorption, calcitropic hormones, Chinese, women, 1,25-dihydroxyvitamin D, parathyroid hormone INTRODUCTION Osteoporosis is in part a disorder of bone remodeling. Although the cause of abnormal bone remodeling is not well See corresponding editorial on page understood, a common feature of the osteoporotic process is a negative calcium balance due to more calcium exiting the skeleton than returning. Two pathophysiologic categories of osteoporosis have been defined. In postmenopausal osteoporosis, the primary defect is estrogen deficiency, with a resultant increase in bone resorption. In age-related osteoporosis, the process of bone remodeling becomes inefficient. The inefficiency relates to either excessive bone resorption or defective bone formation. More likely, it is a combination of both abnormalities. Apart from the critical events that constitute the bone remodeling cycle, the gastrointestinal tract looms as another pathophysiologic focus. Aging is believed to be associated with a defect in the ability to adapt to a low-calcium diet (1, 2). Inefficient absorption or malabsorption of calcium from the gastrointestinal tract can be due to a reduction in renal 1,25-dihydroxyvitamin D formation, a decline in intestinal vitamin D receptors, 25-hydroxyvitamin D deficiency (3 5), or inadequate dietary calcium. These mechanisms are based on Western populations in whom habitual calcium intake is higher than in Asian populations. Calcium intake is an important risk factor for the development of osteoporosis. Recent studies have confirmed that supplementation of the diet with calcium is associated with reduced bone loss (6 8). Recent recommendations by the Food and Nutrition Board of the National Academy of Science increased the dietary reference intake for calcium from 800 to 1000 mg/d for adults (9). Whether the same requirement applies to Asian populations, whose body sizes and skeletons are smaller, is unknown. In Hong Kong, the Chinese diet contains an average calcium content of <500 mg/d (10), much lower than that of a typical Western diet. Whether racial factors in the Chinese serve to enhance calcium absorption is unknown. To begin to address this question, we evaluated fractional calcium absorption, calcitropic 1 From the Departments of Medicine and Orthopaedic Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. 2 Supported by CRCG grants and and grant from the Osteoporosis and Endocrine Research Fund, The University of Hong Kong. 3 Address reprint requests to AWC Kung, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China. awckung@hkucc.hku.hk. Received February 11, Accepted for publication July 2, Am J Clin Nutr 1998;68: Printed in USA American Society for Clinical Nutrition 1291
2 1292 KUNG ET AL hormones, and biochemical bone markers in response to dietary calcium deprivation in a group of elderly osteoporotic subjects and age-matched as well as young healthy control subjects. SUBJECTS AND METHODS Subjects Twenty-five southern Chinese women with postmenopausal osteoporosis were recruited. All osteoporotic subjects had at least one clinically significant vertebral fracture and a total lumbar spine bone mineral density (L1 4 BMD) <2.5 SDs below the mean for a young, control population (t score < 2.5). The women were studied 6 mo after the fracture. Twenty-five agematched, healthy postmenopausal women and 15 healthy, premenopausal women with normal BMDs were also studied. The healthy women were recruited from the community. Women with underlying metabolic or genetic bone disease, with premature menopause (age <40 y), who had had a bilateral ovariectomy, or who used drugs that could affect bone mineral metabolism were excluded. The protocol was approved by the Ethics Committee, the University of Hong Kong. Study design Dietary calcium intake was assessed with a food-frequency questionnaire before the study (11). The study was divided into 4 phases, each of which consisted of a treatment period of 4 wk and a washout period of 2 wk. In the first phase, subjects were given a calcium supplement of 1200 mg/d in 3 divided doses in the form of calcium citrate (Citracal; Mission Pharmacal, San Antonio, TX). During the second phase, subjects received a calcium supplement of 600 mg/d as calcium citrate (200 mg 3 times daily after meals). During the third phase of the study, subjects were advised to return to their unmodified diets. Dietary calcium intake was reassessed by questionnaire during this period. In the final phase, subjects were placed on a low-calcium diet, during which they were asked to avoid foods containing substantial amounts of calcium, such as dairy products, eggs, bean curd and related products, seafood, and calcium-containing vegetables. The low-calcium diet was estimated to contain <300 mg dietary calcium/d. In addition, subjects were given oral phosphate (Phosphate Sandoz, 1 g 3 times daily; Sandoz, Bunchbowl, Australia) with meals to inhibit intestinal calcium absorption. The sequence of high to low calcium intake was used because it is the one under which the adaptation period is defined. Measurements were taken at recruitment and at the end of each study period. Subjects were asked to bring a 24-h urine collection for calcium and creatinine measurement. Fasting blood was obtained for measurement of calcium, phosphorus, albumin, creatinine, total alkaline phosphatase, parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and osteocalcin. A 2-h fasting morning urine sample was also collected for n-telopeptide measurement. Calcium absorption study Fractional 45 Ca absorption was estimated at the end of each treatment phase from the appearance of 45 Ca in blood after the ingestion of 100 ml of an aqueous solution containing 3 Ci 45 Ca and 100 mg cold Ca as the chloride salt (12), followed by ingestion of three 50-mL portions of deionized water. Before ingestion, duplicate 60- L standards were removed from each test dose for counting. Exactly 3 h after ingestion of the tracer, 15 ml blood was drawn. Two 2-mL portions of serum and the standards were each added to 18 ml scintillation fluid and -emissions were counted in a scintillation counter (model 1900TR; Packard Instrument Co, Meridian, CT). Counts were corrected for quenching. In the first 8 women, blood was drawn immediately before the second tracer was administered and counted as described above to evaluate residual counts from the first tracer dose. Residual counts were all <1%, suggesting that the subsequent tracer test was not affected by the previous one. The fraction of 45 Ca absorption index, based on evidence compiled by Manery (13) and used by others (14), is the fraction of the 45 Ca count ingested and multiplied by 15% of body weight. 45 Ca was purchased from Amersham Corp (Buckinghamshire, United Kingdom) and spectral analyses were carried out on each batch before its use to ensure purity. Laboratory assays Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D were measured with kits from Incstar Corporation (Stillwater, MN). Plasma 25-hydroxyvitamin D was extracted with acetonitrile and assayed by an equilibrium radioimmunoassay procedure (Incstar Corporation). The intra- and interassay CVs were 10.6% and 14.9%, respectively. Plasma 1,25-dihydroxyvitamin D was extracted by using C 18 OH and silica cartridges and assayed by using a competitive radioimmunoassay procedure (Incstar). The percentage recovery was monitored by the addition of known amounts of 1,25-dihydroxycholecalciferol (calcitriol) in ethanol in 3 serum samples in each assay. The overall recovery was 105 ± 10%. The intra- and interassay CVs were 7.8% and 8.3%, respectively. Serum intact PTH was measured with chemiluminescence immunometric assay kits from Corning Magic Lite (Chiron Diagnostic Corporation, Medfield, MA) with intra- and interassay CVs of 5.6% and 6.6%, respectively. Serum calcium, phosphorus, albumin, total alkaline phosphatase, and creatinine were measured with a Hitachi 747 random access analyzer (Boehringer Mannheim, Mannheim, Germany). Urinary calcium and creatinine were determined by colorimetric reaction with the Synchron CX5 (Beckman Instruments, Palo Alto, CA). Serum intact osteocalcin was measured by enzyme-linked immunosorbent assay with commercial kits (Novocalcin; Metra Biosystems Inc, Mountain View, CA). The intra- and interassay CVs were 8.8% and 10.1%, respectively. Urinary n-telopeptide was also measured by enzyme-linked immunosorbent assay (Osteomark; Ostex, Seattle). The intra- and interassay CVs were 8.7% and 10.9%, respectively. All samples for individual subjects were measured in a single assay. Densitometry Lumbar spine (L1 4) and femoral neck BMDs were measured by dual-energy X-ray absorptiometry (Hologic QDR 2000 plus; Hologic Inc, Waltham, MA). The in vivo precision of the machine for lumbar spine and femoral neck measurements was 1.2% and 1.5%, respectively. Statistical analysis Baseline values were compared by using one-way analysis of variance (ANOVA) with Tukey s test for repeated comparisons. Results are reported as means ± SDs. For the analysis of longitudinal data, two-factor ANOVA was used to determine the inter-
3 CALCIUM ABSORPTION AND OSTEOPOROSIS IN CHINESE 1293 actions between calcium intakes and between the various patient groups. Tukey s test was used as a post hoc test to compare variables identified as being significant (P < 0.05) by ANOVA between calcium intakes and between the various patient groups. The statistical package used was SPSS for WINDOWS (SPSS Inc, Chicago). n-telopeptide excretion. Serum total alkaline phosphatase and osteocalcin but not urinary n-telopeptide were significantly higher in osteoporotic subjects than in age-matched control subjects. Bone mineral densities were significantly lower in osteoporotic subjects than in age-matched or young control subjects. RESULTS Baseline data Dietary calcium intakes and plasma 25-hydroxyvitamin D concentrations of osteoporotic subjects were not significantly different from those in age-matched or young healthy control subjects (Table 1). None of the subjects had 25-hydroxyvitamin D concentrations < 37.5 mmol/l (15 mg/l). Serum calcium and phosphate concentrations and creatinine clearance were not significantly different between osteoporotic subjects and agematched control subjects, but urinary calcium excretion was higher in osteoporotic subjects. Although PTH concentrations were not significantly different between osteoporotic subjects and age-matched control subjects, plasma 1,25-dihydroxyvitamin D concentrations were significantly decreased in osteoporotic subjects. Compared with young women, the osteoporotic subjects had higher albumin-adjusted serum calcium concentrations and elevated urinary calcium excretion. Furthermore, the osteoporotic subjects had lower plasma 1,25-dihydroxyvitamin D concentrations but elevated serum PTH. Bone turnover was increased in the osteoporotic subjects compared with the agematched or young control subjects as evidenced by elevated serum total alkaline phosphatase, serum osteocalcin, and urinary Longitudinal data Calcitropic hormones The response of the kidneys and gastrointestinal tract to calcium deprivation was studied. With a gradual reduction in calcium intake, serum calcium and urinary calcium excretion decreased in parallel in both age-matched and young control subjects (Table 2). In osteoporotic subjects, although serum calcium concentrations decreased when dietary calcium intake was gradually lowered, urinary calcium excretion was still higher than that in the control subjects, even during calcium deprivation. Serum 25-hydroxyvitamin D was not significantly different throughout the study in all 3 study groups (data not shown). PTH concentrations increased during calcium deprivation in both osteoporotic subjects and age-matched control subjects; concentrations in these subjects were significantly higher than in young control subjects (Figure 1). When subjects were given 1200 mg Ca, PTH concentrations were suppressed in both osteoporotic subjects and age-matched control subjects to concentrations similar to those in young control subjects (2.27 ± 1.09, 2.10 ± 0.80, and 1.89 ± 0.93 pmol/l, respectively). Plasma 1,25-dihydroxyvitamin D increased appropriately during calcium deprivation in the age-matched and young control subjects, but not in the osteoporotic subjects (Figure 2). Plasma 1,25-dihydroxyvitamin D TABLE 1 Baseline characteristics of the study subjects 1 Osteoporotic Age-matched control Young control subjects subjects subjects (n = 25) (n = 25) (n = 15) ANOVA Age (y) 67 ± 6 a 67 ± 6 a 43 ± 6 b < Height (cm) 150 ± 8 a 151 ± 5 b 156 ± 4 b < 0.05 Weight (kg) 51 ± ± 8 53 ± 7 NS Menarche (y) 15 ± 2 15 ± 2 14 ± 2 NS Time since menopause (y) 20 ± 8 20 ± 6 NS Calcium intake (mg/d) 561 ± ± ± 191 NS Bone mineral density Femoral neck (g/cm 2 ) 0.54 ± 0.12 a 0.64 ± 0.08 b 0.78 ± 0.13 c < Lumbar (L2 4) spine (g/cm 2 ) 0.71 ± 0.15 a 0.89 ± 0.14 b 1.02 ± 0.10 c < Biochemical indexes Albumin-adjusted calcium (mmol/l) 2.42 ± 0.08 a 2.40 ± 0.10 a 2.27 ± 0.18 b < 0.05 Serum calcium (mmol/l) 2.39 ± ± ± 0.09 NS Phosphorus (mmol/l) 1.16 ± ± ± 0.19 NS Albumin (g/l) 44 ± 3 46 ± 2 46 ± 2 NS Creatinine ( mol/l) 73 ± 14 a 78 ± 9 a 62 ± 8 b < 0.05 Creatinine clearance (ml/min) 65 ± 18 a 63 ± 12 a 86 ± 21 b < 0.05 Urinary calcium (mol/mol Cr) 0.63 ± 0.47 a 0.28 ± 0.25 b 0.27 ± 0.16 b < 0.05 Plasma calcitropic hormones 25(OH)D (nmol/l) 82 ± ± ± 30 NS 1,25(OH) 2 D (pmol/l) 74 ± 26 a 110 ± 30 b 108 ± 33 b < 0.02 PTH (pmol/l) 3.67 ± 1.54 a 3.37 ± 1.41 a 2.67 ± 1.62 b < 0.05 Bone turnover indexes Total alkaline phosphatase (IU/L) 84 ± 21 a 72 ± 18 b 54 ± 16 b < 0.05 Osteocalcin (mg/l) 9.5 ± 4.2 a 6.7 ± 3.9 b 4.5 ± 2.3 b < 0.05 Urinary NTx (mmol BCE/mol Cr) 50 ± ± ± 15 NS 1 x ± SD. Cr, creatinine; 25(OH)D, 25-hydroxyvitamin D; 1,25(OH) 2 D, 1,25-dihydroxyvitamin D; PTH, parathyroid hormone; NTx, n-telopeptide; BCE, bone collagen equivalent. Means in the same row with different superscript letters are significantly different at the P value shown in the ANOVA column.
4 1294 KUNG ET AL TABLE 2 Changes in biochemical indexes during calcium deprivation mg Ca 600-mg Ca Unmodified Low-calcium Two-factor supplement supplement diet diet ANOVA 2 Total calcium (mmol/l) Osteoporotic subjects 2.41 ± ± ± ± 0.10 D, G Age-matched control subjects 2.41 ± ± ± ± 0.07 Young control subjects 2.41 ± ± ± ± 0.07 Albumin-adjusted calcium (mmol/l) Osteoporotic subjects 2.41 ± ± ± ± 0.09 D, G Age-matched control subjects 2.41 ± ± ± ± 0.09 Young control subjects 2.41 ± ± ± ± 0.08 Phosphorus (mmol/l) Osteoporotic subjects 1.06 ± ± ± ± 0.13 None Age-matched control subjects 1.07 ± ± ± ± 0.13 Young control subjects 1.11 ± ± ± ± 0.20 Urinary calcium (mol/mol Cr) Osteoporotic subjects 0.60 ± ± ± ± 0.19 D, G Age-matched control subjects 0.43 ± ± ± ± 0.20 Young control subjects 0.40 ± ± ± ± x ± SD; n = 25 osteoporotic subjects, 25 age-matched control subjects, and 15 young control subjects. Cr, creatinine. 2 Significant main effects of diet (D), group (G), or a significant D G interaction, P < concentrations in the osteoporotic subjects were significantly lower than in in the age-matched or young control subjects at all times except when they were given the 1200-mg Ca supplement. In the postmenopausal, age-matched, healthy control subjects, plasma 1,25-dihydroxyvitamin D concentrations were not significantly different from those in the young control subjects at all phases of the study. Biochemical bone markers No significant changes were noted in total alkaline phosphatase in all 3 groups during calcium deprivation. The osteoporotic subjects, however, had significantly higher concentrations than those in the young control subjects during all phases of the study (Table 3). In the osteoporotic subjects, significant elevations of serum osteocalcin occurred during the unmodified diet period and the low-calcium diet period compared with the 1200-mg Ca supplementation period. When subjects were given 1200 mg Ca, osteocalcin concentrations were significantly reduced in osteoporotic subjects as well as in age-matched control subjects. TABLE 3 Changes in biochemical bone markers during calcium deprivation 1 Similarly, osteoporotic subjects had significantly higher osteocalcin concentrations than did young control subjects during all phases of the study. Serum osteocalcin remained unchanged during calcium deprivation in the young control subjects. Urinary n-telopeptide excretion in the osteoporotic subjects showed a decreasing trend with both 600-mg and 1200-mg Ca supplementation, but the results were not significant (Table 3). Similar results were observed in the age-matched control subjects. n-telopeptide excretion increased when the young control subjects were consuming the low-calcium diet, but not significantly so. Fractional 45 Ca absorption Fractional 45 Ca absorption during the unmodified diet was 61% in all 3 groups of subjects (Table 4). During the lowcalcium period, 45 Ca absorption was 71%, 71%, and 68% in the osteoporotic, age-matched control subjects, and young control subjects, respectively. These results were not significant when compared with the unmodified diet period. During calcium supplementation, fractional 45 Ca absorption showed a decreasing 1200-mg Ca 600-mg Ca Unmodified Low-calcium Two-factor supplement supplement diet diet ANOVA 2 Alkaline phosphatase (IU/L) Osteoporotic subjects 76 ± ± ± 2 76 ± 21 G Age-matched control subjects 65 ± ± ± ± 17 Young control subjects 55 ± ± ± ± 19 Osteocalcin (mg/l) Osteoporotic subjects 8.07 ± ± ± ± 3.33 D, G Age-matched control subjects 6.07 ± ± ± ± 3.54 Young control subjects 5.00 ± ± ± ± 2.48 Urine NTx (mmol BCE/mol Cr) Osteoporotic subjects 44 ± ± ± ± 30 None Age-matched control subjects 35 ± ± ± ± 28 Young control subjects 29 ± ± 7 32 ± ± 34 1 x ± SD; n = 25 osteoporotic subjects, 25 age-matched control subjects, and 15 young control subjects. NTx, n-telopeptide; BCE, bone collagen equivalent; Cr, creatinine. 2 Significant main effects of diet (D), group (G), or a significant D G interaction, P < 0.05.
5 CALCIUM ABSORPTION AND OSTEOPOROSIS IN CHINESE 1295 FIGURE 1. Mean (± SD) parathyroid hormone (PTH) concentrations of osteoporotic subjects (, n = 25), age-matched control subjects (, n = 25), and young control subjects (, n = 15) during different dietary calcium intakes. * Significantly different from 1200-mg Ca supplementation, P < Significantly different from young control subjects, P < Significance of two-factor ANOVA: diet, P < 0.05; group, P < 0.001; diet group interaction, NS. trend in both the age-matched and the young control subjects, but the results were not significant. Significant differences in fractional 45 Ca absorption between the low-calcium diet and the 1200-mg Ca supplementation period were noted in all 3 groups. However, 45 Ca absorption was suppressed to 49% in the osteoporotic subjects when they were supplemented with 1200 mg Ca. We also examined the interactions between age, group, and calcium intake on fractional absorption and calcitropic hormones. With use of two-factor repeated-measures ANOVA, no significant interactions between age, group, and calcium intake were detected for any of the indexes studied. DISCUSSION Our results showed that fractional 45 Ca absorption was significantly altered by changes in dietary calcium intake, which ranged from >1500 to <300 mg/d. However, no significant differences were detected in fractional 45 Ca absorption between postmenopausal osteoporotic subjects; healthy, age-matched control subjects; and healthy, premenopausal control subjects except during supplementation with 1200 mg Ca. The fractional calcium absorption value obtained in our subjects when they were consuming their unmodified diets (with a daily calcium intake of 500 mg) was similar to the result of 58% obtained in another study performed in young children from the same population by using a double stable-isotope method (15). This suggests that intestinal calcium absorption does not change with aging. Intestinal calcium absorption in our Chinese subjects was more than 2- fold higher than that reported in whites (16) or blacks (17) with similar dietary calcium intakes, which is reported to be 20 30%. Whether this represents a racial difference or just an adaptation to chronically low dietary calcium intakes since childhood in our population is unknown. It is a Chinese custom to wean infants from milk at 6 12 mo of age. Also, 70% of Chinese adults have lactose intolerance and do not consume any dairy products. Thus, vegetables are the main source of dietary calcium (11). There is little doubt that humans can adapt to large changes in dietary intake of calcium. The enhanced calcium absorptive effi- FIGURE 2. Mean (± SD) 1,25-dihydroxyvitamin D [1,25(OH) 2 D] concentrations of osteoporotic subjects (, n = 25), age-matched control subjects (, n = 25), and young control subjects (, n = 15) during different dietary calcium intakes. * Significantly different from 1200-mg Ca supplementation, P < Significantly different from young control subjects, P < Significance of two-factor ANOVA: diet, P < ; group, P < ; diet group interaction, NS.
6 1296 KUNG ET AL TABLE 4 Fractional calcium absorption in Chinese women mg Ca 600-mg Ca Unmodified Low-calcium Two-factor supplement supplement diet diet ANOVA 2 Osteoporotic subjects (n = 25) 49 ± ± ± ± 21 D, G Age-matched control subjects (n = 25) 56 ± ± ± ± 18 Young control subjects (n = 15) 59 ± ± ± 7 68 ± 11 1 x ± SD. 2 Significant main effects of diet (D), group (G), or a significant D G interaction, P < % ciency in this population may represent successful adaptation to generations of low dietary calcium. Furthermore, this efficient intestinal calcium absorption is apparently not impaired by estrogen deficiency due to menopause, so that in healthy, postmenopausal women intestinal calcium absorption was not significantly different from that in premenopausal women at all phases of the study. Also, the efficient intestinal absorption of osteoporotic women apparently overcame the inadequate 1,25-dihydroxyvitamin D production of these subjects because their fractional calcium absorption was not significantly different from that in the young control subjects during the unmodified and the low-calcium diets. When subjects were supplemented with 1200 mg Ca, fractional calcium absorption in the osteoporotic women was promptly suppressed to levels below even those of the healthy control subjects. There is thus no evidence of intestinal malabsorption or defective 1,25-dihydroxyvitamin D action on the gut in these osteoporotic subjects. Although the gastrointestinal tract adapts well to low dietary calcium intakes, the osteoporotic women had significantly higher urinary calcium losses and lower plasma 1,25-dihydroxyvitamin D concentrations during dietary calcium deprivation than did control subjects. The low 1,25-dihydroxyvitamin D concentrations could have been due to either defective renal calcidiol 1-monooxygenase activity or enzyme resistance to the action of PTH (4). We further observed that despite a low 1,25-dihydroxyvitamin D concentration and excessive urinary calcium loss, PTH concentrations in the osteoporotic women were not elevated and there was no evidence of secondary hyperparathyroidism in these subjects. Previous studies conducted in this population also revealed an absence of secondary hyperparathyroidism in patients with hip fracture (18). Our finding of a lack of secondary hyperparathyroidism is in contrast with other reports in white women that age-related bone loss is associated with increased PTH as a result of a negative calcium balance in the body. Thus, to explain the high bone turnover in the presence of low 1,25-dihydroxyvitamin D and normal PTH concentrations in our Chinese osteoporotic women, we postulate that these women had specific differences in bone and calcium homeostasis compared with subjects with normal bone mass, and that they had altered bone turnover responses to changes in calcium intake and abnormal skeletal responses to endogenous 1,25-dihydroxyvitamin D and PTH concentrations. Previous studies of female patients with vertebral fractures also reported evidence of suppression of PTH, consistent with the primary pathophysiologic disorder resulting in the bone (19, 20). Recently, O Brien et al (21) reported that girls and women from osteoporotic families have a significantly altered bone turnover response to acute changes in calcium intake, so that the net balance in bone turnover was significantly lower than in healthy control subjects. This finding also suggests a primary abnormality in the regulation of bone turnover in osteoporotic subjects that is probably genetically determined. In this study, we also gained information about the amount of calcium required to suppress bone turnover in osteoporotic subjects. Supplementation with 1200 mg Ca was associated with suppressed PTH concentrations and lowered serum osteocalcin concentrations, suggesting that this degree of calcium supplementation can retard bone turnover. Failure to detect a significant change in n- telopeptide excretion was probably related to the large biological intraindividual variation in n-telopeptide excretion (22). However, we also observed that with 1200-mg Ca supplementation, 1,25- dihydroxyvitamin D concentrations were further suppressed in these osteoporotic subjects who had preexisting low concentrations. The reduction of plasma 1,25-dihydroxyvitamin D was probably secondary to a reduction in the serum PTH of these patients. Also, supplementation with 1200 mg Ca resulted in a significant reduction in fractional 45 Ca absorption, suggesting that these elderly patients retained a prompt, efficient response of the gastrointestinal tract to changes in dietary calcium content. In conclusion, we observed that Chinese women had efficient intestinal calcium absorption and found no evidence of calcium malabsorption in the osteoporotic subjects. Reductions in 1,25-dihydroxyvitimin D production, persistent urinary calcium loss, and higher bone turnover are important causes for agerelated osteoporosis in Chinese. We thank JP Bilezikian for helpful comments and discussion, SCF Tam for PTH estimation, YY Sha and KS Lau for technical support, and Stanley Yeung for statistical advice. REFERENCES 1. Heaney RP. Skeletal development and maintenance: the role of calcium and vitamin D. Adv Endocrinol Metab 1995;6: Kanis JA. Calcium nutrition and its implications for osteoporosis. Part II. After menopause. Eur J Clin Nutr 1994;48: Morris HA, Need AG, Horowitz M, O Loughlin PD, Nordin EC. Calcium absorption in normal and osteoporotic postmenopausal women. Calcif Tissue Int 1991;49: Tsai KS, Heath H III, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women. J Clin Invest 1984;73: Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT. Deficient production of 1,25(OH) 2 D in elderly osteoporotic patients. N Engl J Med 1981;305: Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323: Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993;328:460 4.
7 CALCIUM ABSORPTION AND OSTEOPOROSIS IN CHINESE Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337: Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press, Pun KK, Chan LWL, Chung V, Wong FHW. Calcium and other dietary constituents in Hong Kong Chinese in relation to age and osteoporosis. J Appl Nutr 1990;43: Pun KK, Chan LWL, Chung V, Wong FHW. Calcium content of common food items in Chinese diet. Calcif Tissue Int 1991; 48: Bhandarkar SD, Bluhm MOL, MacGregor J, Nordin BEC. An isotope test of calcium absorption. Br Med J 1961;2: Manery JF. Water and electrolyte metabolism. Physiol Rev 1954; 34: Marshall DH, Nordin BEC. A comparison of radioactive calcium absorption tests with net calcium absorption. Clin Sci 1981; 61: Lee WT, Leung SS, Xu YC, et al. Effects of double-blind controlled calcium supplementation on calcium absorption in Chinese children measured with stable isotopes ( 42 Ca and 44 Ca). Br J Nutr 1995;73: Heaney RP, Recker RR, Stegman MR, May AJ. Calcium absorption in women: relationships to calcium intake, estrogen status, age. J Bone Miner Res 1989;4: Dawson-Hughes B, Harrison S, Kramich C, Dallal G, Rasmussen HM. Calcium retention and hormone levels in black and white women on high- and low-calcium diets. J Bone Miner Res 1993;8: Pun KK, Wong FH, Wang C, et al. Vitamin D status among patients with fractured neck or femur in Hong Kong. Bone 1990;11: Kotowicz MA, Klee GG, Kao PC, et al. Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type 1 osteoporosis: evidence that skeletal sensitivity is increased. Osteoporosis Int 1990;1: Ebeling PR, Jones JD, Burritt MF. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis. J Clin Endocrinol Metab 1992;75: O Brien KO, Abrams SA, Liang LK, Ellis KJ, Gagel RF. Bone turnover response to changes in calcium intake is altered in girls and adult women in families with histories of osteoporosis. J Bone Miner Res 1998;13: Ju HSJ, Leung S, Brown B, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationIndex. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition
A Acid base balance dietary protein detrimental effects of, 19 Acid base balance bicarbonate effects, 176 in bone human studies, 174 mechanisms, 173 174 in muscle aging, 174 175 alkali supplementation
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationDietary Protein and Bone Health Emphasis: Animal Protein
USDA-ARS Human Nutrition Research Centers Dietary Protein and Bone Health Emphasis: Animal Protein Z.K. (Fariba) Roughead, PhD, RD Research Nutritionist USDA-ARS Grand Forks Human Nutrition Research Center
More informationCa, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary
Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular
More informationnogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,
More informationCalcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014
HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research
More informationThe efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial
Osteoporos Int () 4:87 877 DOI.7/s98-87-5 ORIGINAL ARTICLE The efficacy of calcium supplementation alone in elderly Thai women over a -year period: a randomized controlled trial R. Rajatanavin & L. Chailurkit
More informationRelative bioavailability of calcium-rich dietary sources in the elderly 1 4
Relative bioavailability of calcium-rich dietary sources in the elderly 1 4 Ligia Martini and Richard J Wood ABSTRACT Background: The recent increase in the dietary calcium recommendation from 800 to 1200
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationDiagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.
Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014 Case 1 71-year old woman Back pain Emergency
More informationRobin M Daly, Nicole Petrass, Shona Bass, and Caryl A Nowson
The skeletal benefits of calcium- and vitamin D 3 fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study 1 3 Robin M Daly, Nicole Petrass, Shona Bass, and
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism
Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or
More informationForteo (teriparatide) Prior Authorization Program Summary
Forteo (teriparatide) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1 FDA Indication 1 : Forteo (teriparatide) is indicated for: the treatment of postmenopausal women with osteoporosis
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationBiochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake 1 3
Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake 1 3 Patrice Fardellone, Michel Brazier, Saïd Kamel, Jean Guéris, Anne-Marie Graulet, Jacques
More informationPharmacy Management Drug Policy
SUBJECT: - Forteo (teriparatide), Prolia (denosumab), Tymlos (abaloparatide) POLICY NUMBER: Pharmacy-35 EFFECTIVE DATE: 9/07 LAST REVIEW DATE: 9/29/2017 If the member s subscriber contract excludes coverage
More information9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationAdditional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.
Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015 Dr. Tessem Osteoporosis is a public health problem in all stages of life. Many
More informationSerum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3
See corresponding editorial on page 673. Serum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3 John F Aloia, Ding-Geng Chen, James K Yeh, and Henian Chen ABSTRACT Background:
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationVitamin D Deficiency. Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver
Vitamin D Deficiency Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver 50 yo woman referred for osteoporosis What is striking about her
More informationBone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017
Bone Health in Celiac Disease Partha S. Sinha MD, PhD October 29 th, 2017 No Disclosures Objectives Recognize the mechanisms by which celiac disease can affect bone health Review what diagnostic tests
More informationEndocrine Regulation of Calcium and Phosphate Metabolism
Endocrine Regulation of Calcium and Phosphate Metabolism Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C516, Block C, Research Building, School of Medicine Tel: 88208252 Email: wanghuiping@zju.edu.cn
More informationBreast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime
Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy
More informationShon E. Meek, M.D., Ph.D. Assistant Professor of Medicine
Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine meek.shon@mayo.edu 2016 MFMER 3561772-1 Update on Vitamin D Shon Meek MD, PhD 20 th Annual Endocrine Update January 30-Feb 3, 2017 Disclosure Relevant
More informationVitamin D and Calcium
Vitamin D and Calcium American Association of Clinical Endocrinologists Marina Del Rey, CA September 15, 2018 Albert Shieh, MD MS Assistant Clinical Professor Department of Medicine Division of Endocrinology
More informationHigh Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker
J Bone Metab 214;21:189-194 http://dx.doi.org/1.115/jbm.214.21.3.189 pissn 2287-6375 eissn 2287-729 Original Article High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 116 No 1179 ISSN 1175 8716 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency Fiona Wu, Toni Staykova, Anne Horne, Judy Clearwater,
More informationThe Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake
Korean J Fam Med. 2013;34:43-48 http://dx.doi.org/10.4082/kjfm.2013.34.1.43 The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake Original Article Junga Kim, Byungsung
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationVitamin D Status of an Outpatient Clinic Population
Calcif Tissue Int (2001) 69:263 267 DOI: 10.1007/s002230010054 2001 Springer-Verlag New York Inc. Vitamin D Status of an Outpatient Clinic Population L. Margiloff, 1 S. S. Harris, 2 S. Lee, 3 R. Lechan,
More informationPOSTMENOPAUSAL BONE LOSS poses a significant
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(6):3528 3533 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-2451 Effects of Potassium Alkali
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More informationAssociations Between Liver Function, Bone Turnover Biomarkers and Adipokines in Older Patients With Hip Fracture
Elmer ress Original Article J Endocrinol Metab. 2014;4(5-6):121-135 Associations Between Liver Function, Bone Turnover Biomarkers and Adipokines in Older Patients With Hip Fracture Leon Fisher a, d, Alexander
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationORIGINAL COMMUNICATION
(2004) 58, 1420 1424 & 2004 Nature Publishing Group All rights reserved 0954-3007/04 $30.00 www.nature.com/ejcn ORIGINAL COMMUNICATION Calcium and vitamin D 3 supplements in calcium and vitamin D 3 sufficient
More informationDisclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco Disclosure and Conflicts of Interest
More informationPresented by: Michelle Darr February 5, 2013
Total calcium absorption is similar from infant formulas with and without prebiotics and exceeds that in human milk-fed infants Penni D Hicks1, 2,3*, Keli Hawthorne1, 2, Carol L Berseth3, John D Marunycz3,
More informationVitamin D Hormone Du Jour
Vitamin D Hormone Du Jour J R Minkoff MD, FACP Endocrinology Clinical Professor of Family and Community Medicine UCSF Why Is Vitamin D Important? Musculo-skeletal effects Possible other effects Immunomodulatory
More informationCalcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-up 1 3
Calcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-up 1 3 Helen L Lambert, Richard Eastell, Kavita Karnik, Jean M Russell, and
More informationCoordinator of Post Professional Programs Texas Woman's University 1
OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic
More informationPharmacy Management Drug Policy
SUBJECT: - Forteo (teriparatide), Prolia (denosumab), Tymlos (abaloparatide), Boniva injection (Ibandronate) POLICY NUMBER: Pharmacy-35 EFFECTIVE DATE: 9/07 LAST REVIEW DATE: 10/15/2018 If the member s
More informationCIC EDIZIONI INTERNAZIONALI. Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men.
Brigitte Uebelhart François Herrmann René Rizzoli Division of Bone Diseases [WHO Collaborating Center for Osteoporosis Prevention], Department of Rehabilitation and Geriatrics, Geneva University Hospitals
More informationV t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s
Vitamin D and Calcium: Role in Prevention and Treatment of Fractures and Falls Osteoporosis 21: New Insights In Research, Diagnosis, and Clinical Care Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic
More informationoriginal Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2)
Endocrine Journal 2014, 61 (12), 1197-1204 original Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National Health and Nutrition Examination
More informationBONE HEALTH BASICS. Promoting Healthy Bones: Sorting Out the Science. Learning Objectives. Guest Speaker
Copyright 11 by the Preventive Cardiovascular Nurses Association Promoting Healthy Bones: Sorting Out the Science Guest Speaker Robert P. Heaney, MD, FACP, FASN Professor and Professor of Medicine Creighton
More informationEFFECT OF DIETARY CATION-ANION DIFFERENCE ON MINERAL BALANCE IN WEANLING HORSES. Authors:
EFFECT OF DIETARY CATION-ANION DIFFERENCE ON MINERAL BALANCE IN WEANLING HORSES 1999 Animal Science Research Report Authors: Story in Brief Pages 182-188 S.R. Cooper, D.R. Topliff, D.W. Freeman, J.E. Breazile
More informationFragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey
Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone
More informationWHAT KEEPS OUR BONES STRONG?
WHAT KEEPS OUR BONES STRONG? The role of diet and lifestyle in osteoporosis prevention Thomas Walczyk PhD, Associate Professor Food Science and Technology Programme Department of Chemistry, Faculty of
More informationPRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery
ENDOCRINE DISORDER PRIMARY HYPERPARATHYROIDISM Roseann P. Velez, DNP, FNP Francis J. Velez, MD, FACS Common Complex Insidious Chronic Global Only cure is surgery HYPERPARATHYROIDISM PARATHRYOID GLANDS
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationCALCIUM INTAKE MAY be one of the many factors that
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):707 711 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-1380 Lack of Effect of Calcium Intake
More informationOverview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence
Overview Osteoporosis and Metabolic Bone Disease Dr Chandini Rao Consultant Rheumatologist Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases Bone Biology Osteoporosis Increased bone remodelling
More informationBone Densitometry Pathway
Bone Densitometry Pathway The goal of the Bone Densitometry pathway is to manage our diagnosed osteopenic and osteoporotic patients, educate and monitor the patient population at risk for bone density
More informationThe effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women
European Journal of Clinical Nutrition (1997) 51, 394±399 ß 1997 Stockton Press. All rights reserved 0954±3007/97 $12.00 in premenopausal and postmenopausal women CEL Evans, AY Chughtai, A Blumsohn, M
More informationEuropean Journal of Endocrinology (1997) ISSN
European Journal of Endocrinology (1997) 137 167 171 ISSN 0804-4643 Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing
More informationProtocol GTC : A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients.
Protocol GTC-68-208: A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients. These results are supplied for informational purposes only.
More informationLong-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women 1 4
Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women 1 4 Christopher Jensen, Leah Holloway, Gladys Block, Gene Spiller, Ginny
More informationDietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites 1-3
Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites 1-3 H Karimi Kinyamu, J Christopher Gallagher, Karen A Rafferty, and Kurt E Balhorn
More informationLu Wu, Berdine R Martin, Michelle M Braun, Meryl E Wastney, George P McCabe, Linda D McCabe, Linda A DiMeglio, Munro Peacock, and Connie M Weaver
ORIGINAL ARTICLE JBMR Calcium Requirements and Metabolism in Chinese-American Boys and Girls Lu Wu, Berdine R Martin, Michelle M Braun, Meryl E Wastney, George P McCabe, Linda D McCabe, Linda A DiMeglio,
More informationCalcium Marie Dunford, PhD, MD, Nutrition Consultant, Kingsburg, CA
Calcium Marie Dunford, PhD, MD, Nutrition Consultant, Kingsburg, CA Calcium is an essential mineral and a major nutrient needed for proper bone health. Absorption of calcium in adults is low. Vitamin D
More informationAGE-RELATED HIP fracture is common in both men and
0021-972X/00/$03.00/0 Vol. 85, No. 9 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Effect of Calcium or 25OH Vitamin D 3 Dietary Supplementation
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Prevalence and Pattern of Mineral Bone Disorder in Chronic Kidney Disease Patients Using Serum
More informationPharmacy Management Drug Policy
Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community. Guidelines
More informationPersistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019
Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal
More informationBone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationWhat Healthcare Providers Need to Know About Calcium & Vitamin D
What Healthcare Providers Need to Know About Calcium & Vitamin D Berdine R. Martin, PhD Department of Nutrition Science Purdue University West Lafayette, IN Disclosures Today s presentation is being sponsored
More informationThe New England Journal of Medicine EFFECT OF CALCIUM AND VITAMIN D SUPPLEMENTATION ON BONE DENSITY IN MEN AND WOMEN 65 YEARS OF AGE OR OLDER
EFFECT OF CALCIUM AND VITAMIN D SULEMENTATION ON BONE DENSITY IN MEN AND WOMEN 65 YEARS OF AGE OR OLDER BESS DAWSON-HUGHES, M.D., SUSAN S. HARRIS, D.SC., ELIZABETH A. KRALL, H.D., AND GERARD E. DALLAL,
More informationJBMR. Serum 25-hydroxyvitamin D [25(OH)D] concentration may or
ORIGINAL ARTICLE JBMR Impact of Calcium and Vitamin D Insufficiencies on Serum Parathyroid Hormone and Bone Mineral Density: Analysis of the Fourth and Fifth Korea National Health and Nutrition Examination
More informationCalcium and vitamin D nutrition and bone disease of the elderly
Public Health Nutrition: 4(2B), 547±559 DOI: 10.1079/PHN2001140 Calcium and vitamin D nutrition and bone disease of the elderly C Gennari* Institute of Internal Medicine, University of Siena, Italy Abstract
More informationBone Mineral Density and Its Associated Factors in Naresuan University Staff
Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan
More informationGuideline for the investigation and management of osteoporosis. for hospitals and General Practice
Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density
More informationOriginal Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism
www.ijcem.com/ijcem807001 Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism Itoko Hisa 1, Hiroshi Kaji 1, Yoshifumi
More informationInterpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm
Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis
More informationESPEN Congress Prague 2007
ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus
More informationIN WOMEN, serum estradiol is an important determinant
0021-972X/98/$03.00/0 Vol. 83, No. 7 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1998 by The Endocrine Society Associations between Low Levels of Serum Estradiol, Bone
More informationK K MK-4 MK-4 1,25-D3
22 5 13 D 25-Hydroxyvitamin D Gla K K D K D K K K -4MK-4 MK-4 MK-4 steriod and xenobiotic receptorsxr MK-4 SXR MK-4 K MK-4 D 1,25-D3 D 1 CYP27B1CYP27B1-KO D CYP27B1-KO D D CYP27B1-KO Ca 1,25-D3 D Vitamin
More informationSponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: sanofi-aventis and
More informationClinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D
Clinical Policy: Reference Number: CP.MP.152 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationOsteoporosis and Nutrition Module 4 Speaking of Bones Osteoporosis For Health Professionals. Susan J Whiting University of Saskatchewan
Osteoporosis and Nutrition Module 4 Speaking of Bones Osteoporosis For Health Professionals Susan J Whiting University of Saskatchewan Learning Objectives Understand the 3 critical nutrients for bone:
More informationParathyroid hormone (serum, plasma)
Parathyroid hormone (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Parathyroid hormone (PTH) 1.2 Alternative names Parathormone 1.3 NMLC code 1.4 Description of analyte PTH is an
More informationDr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk
Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one
More informationVitamin D for the Prevention of Osteoporotic Fractures
TITLE: Vitamin D for the Prevention of Osteoporotic Fractures AUTHOR: Jeffrey A. Tice, MD Assistant Professor of Medicine Division of General Internal Medicine Department of Medicine University of California
More informationOsteoporosis/Fracture Prevention
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
More informationTREATMENT OF OSTEOPOROSIS
TREATMENT OF OSTEOPOROSIS Summary Prevention is the key issue in the management of osteoporosis. HRT is the agent of choice for prevention of postmenopausal osteoporosis. Bisphosphonates and Calcitonin
More informationMOST PATIENTS WITH primary hyperparathyroidism
0013-7227/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(3):1174 1178 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2002-020667 Raloxifene Lowers Serum Calcium
More informationMen and Osteoporosis So you think that it can t happen to you
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
More informationOF DIETARY CATION-ANION BALANCE ON MINERAL BALANCE IN HORSES. Story In Brief
EFFECf OF DIETARY CATION-ANION BALANCE ON MINERAL BALANCE IN HORSES L. A. Bakerl, D.R. Topliff2, D.W. Freeman2, RG. Teeter3 and I.E. Breazile4 Story In Brief Four mature sedentary geldings were used in
More informationAmani Alghamdi. Slide 1
Minerals in the body Amani Alghamdi Slide 1 The Minerals Small, naturally occurring, inorganic, chemical elements Serve as structural components Minerals classification The minerals present in the body
More informationMEDICAL POLICY EFFECTIVE DATE: 08/21/14 REVISED DATE: 04/16/15, 06/16/16, 07/20/17 SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY
MEDICAL POLICY SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY A nonprofit independent licensee of the BlueCross BlueShield Association PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not
More information8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview
Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology
More informationOral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis
Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis Miriam Silverberg A. Study Purpose and Rationale More than 70% of fractures in people after the age of
More informationBenefits of Calcium and Vitamin D: Building and Maintaining Healthy Bones
Benefits of Calcium and Vitamin D: Building and Maintaining Healthy Bones Prepared by Annette Dickinson, Ph.D. Council for Responsible Nutrition June 2002 There is no question that a generous intake of
More information